This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Siegel RL, Miller KD, Jemal A. CA Cancer J Clin. 2018; 68:7–30.SiegelRLMillerKDJemalACA Cancer J Clin20186873010.3322/caac.2144229313949Search in Google Scholar
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Cancer Res. 2014; 74: 2913–2921.RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLMCancer Res2014742913292110.1158/0008-5472.CAN-14-015524840647Search in Google Scholar
American Cancer Society. Cancer facts & figures 2017.American Cancer SocietyCancer facts & figures 2017Search in Google Scholar
Van der Rhee H, Coebergh JW, de Vries E. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer. 2013; 49:1422–1436.Van der RheeHCoeberghJWde VriesEIs prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studiesEur J Cancer2013491422143610.1016/j.ejca.2012.11.00123237739Search in Google Scholar
Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 2011; 29:1599–1606.NgKSargentDJGoldbergRMMeyerhardtJAGreenEMPitotHCVitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741J Clin Oncol2011291599160610.1200/JCO.2010.31.7255308297821422438Search in Google Scholar
Holick MF. Vitamin D deficiency. N Engl J Med, 2007; 357, 266–281.HolickMFVitamin D deficiencyN Engl J Med200735726628110.1056/NEJMra07055317634462Search in Google Scholar
Jacobs ET, Kohler LN, Kunihiro AG, Jurutka PW. Vitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidence. J Cancer, 2016; 7, 232–240.JacobsETKohlerLNKunihiroAGJurutkaPWVitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidenceJ Cancer2016723224010.7150/jca.13403474787626918035Search in Google Scholar
Waterhouse M, Risch HA, Bosetti C, Anderson KE, Petersen GM, Bamlet WR, et al. Vitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortium. Ann Oncol 2015; 26:1776–83.10.1093.WaterhouseMRischHABosettiCAndersonKEPetersenGMBamletWRVitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortiumAnn Oncol201526177683.10.1093.10.1093/annonc/mdv236451122125977560Search in Google Scholar
Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013; 5:3993–4021.10.3390/nu5103993.MoukayedMGrantWBMolecular link between vitamin D and cancer preventionNutrients201353993402110.3390/nu5103993382005624084056Open DOISearch in Google Scholar
Jorde R, Grimnes G. Vitamin D and health: the need for more randomized controlled trials. J Steroid Biochem Mol Biol. 2015; 148:269–74.10.1016.JordeRGrimnesGVitamin D and health: the need for more randomized controlled trialsJ Steroid Biochem Mol Biol20151482697410.1016.10.1016/j.jsbmb.2015.01.02125636723Search in Google Scholar
Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D (3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012; 97:614–22.10.1210.AvenellAMacLennanGSJenkinsonDJMcPhersonGCMcDonaldAMPantPRLong-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D (3) and/or calcium (RECORD trial)J Clin Endocrinol Metab2012976142210.121010.1210/jc.2011-130922112804Search in Google Scholar
Grant WB. A Review of the Evidence Supporting the Vitamin D Cancer Prevention Hypothesis in 2017. Anticancer Res. 2018; 38:1121–1136.GrantWBA Review of the Evidence Supporting the Vitamin D Cancer Prevention Hypothesis in 2017Anticancer Res2018381121113610.21873/anticanres.12331Search in Google Scholar
Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab. 2010; 95:2630–2633.GallagherJCSaiAJVitamin D insufficiency, deficiency, and bone healthJ Clin Endocrinol Metab2010952630263310.1210/jc.2010-0918290206220525913Search in Google Scholar
Cannon TL, Ford J, Hester D, Trump DL. The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer. Case Reports in Pancreatic Cancer Volume 2.1, 2016.CannonTLFordJHesterDTrumpDLThe Incidental Use of High-Dose Vitamin D3 in Pancreatic CancerCase Reports in Pancreatic Cancer21201610.1089/crpc.2016.0003631968430631812Search in Google Scholar
Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O’Reilly EM, Fuchs C, Innocenti F, Venook AP; Alliance for Clinical Trials in Oncology. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014: 6;106.Van LoonKOwzarKJiangCKindlerHLMulcahyMFNiedzwieckiDO’ReillyEMFuchsCInnocentiFVenookAPAlliance for Clinical Trials in Oncology. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance)J Natl Cancer Inst2014610610.1093/jnci/dju185415543125099612Search in Google Scholar
Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men J Natl Cancer Inst. 2006;5;98:451–459.GiovannucciELiuYRimmEBHollisBWFuchsCSStampferMJProspective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in MenJ Natl Cancer Inst200659845145910.1093/jnci/djj10116595781Search in Google Scholar
Cho M, Peddi PF, Ding K, Chen L, Thomas D, Wang J, et al. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. J Transl Med. 2013; 11:206.ChoMPeddiPFDingKChenLThomasDWangJVitamin D deficiency and prognostics among patients with pancreatic adenocarcinomaJ Transl Med.20131120610.1186/1479-5876-11-206384442324011168Search in Google Scholar
Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, et al. Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3. Tumour Biol. 2015; 36:2631–2640.HaasMKernCKrugerSMichlMModestDPGiessenCAssessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3Tumour Biol2015362631264010.1007/s13277-014-2885-x25472579Search in Google Scholar
McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB. Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer. Nutr J. 2016; 15:17.McGovernEMLewisMENiesleyMLHuynhNHoagJBRetrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancerNutr J.2016151710.1186/s12937-016-0135-3475174626867933Search in Google Scholar
Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, et al. 25-Hydroxy vitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014; 106.Van LoonKOwzarKJiangCKindlerHLMulcahyMFNiedzwieckiD25-Hydroxy vitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance)J Natl Cancer Inst.201410610.1093/jnci/dju185Search in Google Scholar
Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, et al. Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival. J Clin Oncol. 2016; 34:2899–2905.YuanCQianZRBabicAMorales-OyarvideVRubinsonDAKraftPPrediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survivalJ Clin Oncol2016342899290510.1200/JCO.2015.66.3005501266227325858Search in Google Scholar
Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012; 23:363–370.TretliSSchwartzGGTorjesenPARobsahmTESerum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based studyCancer Causes Control20122336337010.1007/s10552-011-9885-6326140022193397Search in Google Scholar
Zhang X, Huang XZ, Chen WJ, Wu J, Chen Y, Wu CC, et al. Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget. 2017: 29; 8:64395–64406ZhangXHuangXZChenWJWuJChenYWuCCPlasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysiOncotarget2017298643956440610.18632/oncotarget.18888561001128969079Search in Google Scholar
Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, et al. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One. 2017; 12: e0170791.GakschMJordeRGrimnesGJoakimsenRSchirmerHWilsgaardTVitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortiumPLoS One.201712e017079110.1371/journal.pone.0170791531292628207791Search in Google Scholar
Duffy MJ, Murray A, Synnott NC, O’Donovan N, Crown J. Vitamin D analogues: Potential use in cancer treatment. Crit Rev Oncol Hematol. 2017; 112:190–197DuffyMJMurrayASynnottNCO’DonovanNCrownJVitamin D analogues: Potential use in cancer treatmentCrit Rev Oncol Hematol.201711219019710.1016/j.critrevonc.2017.02.01528325259Search in Google Scholar
Van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, et al. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Int J Cancer. 2018; 15; 142:1189–1201.Van DuijnhovenFJBJenabMHveemKSiersemaPDFedirkoVDuellEJCirculating concentrations of vitamin D in relation to pancreatic cancer risk in European populationsInt J Cancer.2018151421189120110.1002/ijc.31146581321929114875Search in Google Scholar
Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15:1688–1695.SkinnerHGMichaudDSGiovannucciEWillettWCColditzGAFuchsCSVitamin D intake and the risk for pancreatic cancer in two cohort studiesCancer Epidemiol Biomarkers Prev2006151688169510.1158/1055-9965.EPI-06-020616985031Search in Google Scholar
Stolzenberg-Solomon RZ, Vieth R, Azad A, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006; 66:10213–10219.Stolzenberg-SolomonRZViethRAzadAA prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokersCancer Res200666102131021910.1158/0008-5472.CAN-06-187617047087Search in Google Scholar
Stolzenberg-Solomon RZ, Hayes RB, Horst RL, et al. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009; 69:1439–1447.Stolzenberg-SolomonRZHayesRBHorstRLSerum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trialCancer Res2009691439144710.1158/0008-5472.CAN-08-2694305220019208842Search in Google Scholar